Cargando…
Exploration of and insights into advanced topical nanocarrier systems for the treatment of psoriasis
Psoriasis is a chronic inflammatory skin disease with an underlying autoimmune pathogenesis that has brought great distress to patients. Current treatment options include topical therapy, systemic therapy, and phototherapy. By disrupting the stratum corneum, nanocarriers have unique advantages in al...
Autores principales: | Zhang, Miao, Hong, Seokgyeong, Sun, Xiaoying, Zhou, Yaqiong, Luo, Ying, Liu, Liu, Wang, Jiao, Wang, Chunxiao, Lin, Naixuan, Li, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797688/ https://www.ncbi.nlm.nih.gov/pubmed/36590975 http://dx.doi.org/10.3389/fmed.2022.1017126 |
Ejemplares similares
-
Adverse events associated with anti-IL-17 agents for psoriasis and psoriatic arthritis: a systematic scoping review
por: Wang, Jiao, et al.
Publicado: (2023) -
Efficacy and safety of Chinese herbal medicine for atopic dermatitis: Evidence from eight high-quality randomized placebo-controlled trials
por: Cai, Xiaoce, et al.
Publicado: (2022) -
Current evidence on the role of lipid lowering drugs in the treatment of psoriasis
por: Wang, Jiao, et al.
Publicado: (2022) -
Establishment of Mouse Models of Psoriasis with Blood Stasis Syndrome Complicated with Glucose and Lipid Metabolism Disorders
por: Luo, Ying, et al.
Publicado: (2019) -
Updated Evidence of the Association Between Elevated Serum Uric Acid Level and Psoriasis
por: Zhang, Ying, et al.
Publicado: (2021)